Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 94.00 | 104.75 | 0.8974 | 0.5071 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 97.00 | 104.75 | 0.9260 | 0.6361 | |
| SK-BR-3 | Etoposide | 10 | uM | 3 | 156.25 | 80.34 | 94.00 | 104.75 | 0.8974 | 0.5071 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 111.00 | 104.75 | 1.0597 | 1.3270 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 106.00 | 104.75 | 1.0119 | 1.0630 | |
| SK-BR-3 | Etoposide | 1 | uM | 3 | 156.25 | 80.34 | 104.00 | 104.75 | 0.9928 | 0.9628 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 156.25 | 80.34 | 111.00 | 104.75 | 1.0597 | 1.3270 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 3 | 156.25 | 80.34 | 121.00 | 104.75 | 1.1551 | 1.9153 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 156.25 | 80.34 | 120.00 | 104.75 | 1.1456 | 1.8528 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 156.25 | 80.34 | 153.00 | 104.75 | 1.4606 | 4.3824 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 156.25 | 80.34 | 108.00 | 104.75 | 1.0310 | 1.1662 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 164.00 | 104.75 | 1.5656 | 5.4531 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 3 | 156.25 | 80.34 | 116.00 | 104.75 | 1.1074 | 1.6110 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 156.25 | 80.34 | 142.00 | 104.75 | 1.3556 | 3.4290 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 156.25 | 80.34 | 133.00 | 104.75 | 1.2697 | 2.7325 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 156.25 | 80.34 | 92.00 | 104.75 | 0.8783 | 0.4248 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 156.25 | 80.34 | 139.00 | 104.75 | 1.3270 | 3.1886 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 156.25 | 80.34 | 114.00 | 104.75 | 1.0883 | 1.4950 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 156.25 | 80.34 | 109.00 | 104.75 | 1.0406 | 1.2190 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 156.25 | 80.34 | 81.00 | 104.75 | 0.7733 | 0.0215 |
| SK-BR-3 | PLX-4720 | 1 | uM | 3 | 156.25 | 80.34 | 119.00 | 104.75 | 1.1360 | 1.7911 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 156.25 | 80.34 | 43.00 | 104.75 | 0.4105 | -0.8048 |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 65.00 | 104.75 | 0.6205 | -0.4252 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 50.00 | 104.75 | 0.4773 | -0.7104 | |
| SK-BR-3 | 0 | uM | 3 | 156.25 | 80.34 | 87.00 | 104.75 | 0.8306 | 0.2312 |